Transactions of the American Mathematical Society, ISSN 0002-9947, 12/2019, Volume 372, Issue 12, pp. 8679 - 8707
We explain how to compute top-dimensional intersections of \psi -classes on \overline {M}_{1,n}(m), the moduli space of m-stable curves. On the spaces...
Journal Article
Applied Physics Letters, ISSN 0003-6951, 07/2018, Volume 113, Issue 3, p. 32403
We have performed systematic density functional calculations and evaluated thermoelectric properties (Seebeck coefficient and anomalous Nernst coefficient) of...
OPTICAL-PROPERTIES | PHASES | TRANSPORT | PHYSICS, APPLIED | METAL | MAGNETIC-PROPERTIES | Physics - Materials Science
OPTICAL-PROPERTIES | PHASES | TRANSPORT | PHYSICS, APPLIED | METAL | MAGNETIC-PROPERTIES | Physics - Materials Science
Journal Article
Journal für die reine und angewandte Mathematik (Crelles Journal), ISSN 0075-4102, 12/2016, Volume 2016, Issue 721, pp. 1 - 41
We give a precise formulation of the modularity principle for the log canonical models of the moduli space of stable curves. We define a new invariant of...
Journal Article
Earth, Planets and Space, ISSN 1343-8832, 2011, Volume 63, Issue 7, pp. 609 - 614
The devastating M-w 9.0 earthquake on March 11, 2011 is one of the most complex earthquakes of all the recent large events. Its source region is compact for an...
Rupture properties | Back projection | Frequency dependence | High frequency | frequency dependence | GEOSCIENCES, MULTIDISCIPLINARY | JAPAN TRENCH | rupture properties | high frequency
Rupture properties | Back projection | Frequency dependence | High frequency | frequency dependence | GEOSCIENCES, MULTIDISCIPLINARY | JAPAN TRENCH | rupture properties | high frequency
Journal Article
Optics Letters, ISSN 0146-9592, 01/2018, Volume 43, Issue 2, pp. 202 - 205
A 2 μm Ho-doped ytrrium lithium fluoride (Ho:YLF) laser end-pumped by a 1.94 μm Tm:fiber laser was developed. A laser system of a ring resonator oscillator and...
Journal Article
Optics Letters, ISSN 0146-9592, 04/2006, Volume 31, Issue 8, pp. 1103 - 1105
Journal Article
Ergodic Theory and Dynamical Systems, ISSN 0143-3857, 04/2018, Volume 40, Issue 1, pp. 1 - 8
For each $n\geq 2$, we investigate a family of iterated function systems which is parameterized by a common contraction ratio $s\in \mathbb{D}^{\times }\equiv...
Journal Article
EARTH PLANETS AND SPACE, ISSN 1880-5981, 01/2018, Volume 70
The status and initial products of the 1-mu m camera onboard the Akatsuki mission to Venus are presented. After the successful retrial of Venus' orbit...
VENUS WINDS | Infrared | CLOUD | VOLCANISM | GALILEO | ORBITER | Nightside surface | HCL | GEOSCIENCES, MULTIDISCIPLINARY | Venus | SURFACE | Dayside cloud | INFRARED IMAGES
VENUS WINDS | Infrared | CLOUD | VOLCANISM | GALILEO | ORBITER | Nightside surface | HCL | GEOSCIENCES, MULTIDISCIPLINARY | Venus | SURFACE | Dayside cloud | INFRARED IMAGES
Journal Article
Surgery Today, ISSN 0941-1291, 11/2019, Volume 49, Issue 11, pp. 981 - 984
Lateral lymph node dissection (LLND) for recurrence of lateral pelvic lymph node metastasis after rectal cancer surgery is technically demanding because of the...
Extraperitoneal approach | Totally extraperitoneal (TEP) | Medicine & Public Health | Surgical Oncology | Surgery | Lateral lymph node dissection | Medical colleges | Care and treatment | Gastrointestinal diseases | Colorectal cancer | Laparoscopic surgery | Laparoscopy | Metastasis | Methods
Extraperitoneal approach | Totally extraperitoneal (TEP) | Medicine & Public Health | Surgical Oncology | Surgery | Lateral lymph node dissection | Medical colleges | Care and treatment | Gastrointestinal diseases | Colorectal cancer | Laparoscopic surgery | Laparoscopy | Metastasis | Methods
Journal Article
10.
Full Text
An unusual case of Aβ2M amyloid deposition in bladder cancer in a non‐dialysis patient
Pathology International, ISSN 1320-5463, 04/2019, Volume 69, Issue 4, pp. 224 - 228
β2‐microglobulin‐related (Aβ2M) amyloidosis (dialysis‐associated amyloidosis) is a common complication in long‐term dialysis patients. An increased...
Aβ2M amyloid | non‐dialysis patient | dialysis‐related amyloidosis | non-dialysis patient | dialysis-related amyloidosis | Urothelium - metabolism | Amyloidosis - pathology | Carcinoma, Transitional Cell | Urinary Bladder - metabolism | Urinary Bladder Neoplasms - diagnosis | Humans | beta 2-Microglobulin - urine | Male | Urinary Bladder - pathology | Urothelium - pathology | beta 2-Microglobulin - blood | Amyloid - metabolism | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | beta 2-Microglobulin - metabolism | Amyloidosis - classification | Urinary Bladder Neoplasms - metabolism | Amyloidosis - metabolism | Urine | Immunohistochemistry | Typing | Hemodialysis | Pathogenesis | Bladder | Mass spectroscopy | Liquid chromatography | Bladder cancer | Biomedical materials | Cattle | Biocompatibility | Amyloidosis | Dialysis | Urothelial carcinoma | Mass spectrometry | Deposition | Cancer
Aβ2M amyloid | non‐dialysis patient | dialysis‐related amyloidosis | non-dialysis patient | dialysis-related amyloidosis | Urothelium - metabolism | Amyloidosis - pathology | Carcinoma, Transitional Cell | Urinary Bladder - metabolism | Urinary Bladder Neoplasms - diagnosis | Humans | beta 2-Microglobulin - urine | Male | Urinary Bladder - pathology | Urothelium - pathology | beta 2-Microglobulin - blood | Amyloid - metabolism | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | beta 2-Microglobulin - metabolism | Amyloidosis - classification | Urinary Bladder Neoplasms - metabolism | Amyloidosis - metabolism | Urine | Immunohistochemistry | Typing | Hemodialysis | Pathogenesis | Bladder | Mass spectroscopy | Liquid chromatography | Bladder cancer | Biomedical materials | Cattle | Biocompatibility | Amyloidosis | Dialysis | Urothelial carcinoma | Mass spectrometry | Deposition | Cancer
Journal Article
Optics Express, ISSN 1094-4087, 01/2009, Volume 17, Issue 1, pp. 62 - 69
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 25, pp. 2827 - 2838
Abstract Background Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients...
Cardiovascular | Internal Medicine | registry | risk | aortic valve replacement | propensity-matched | watchful waiting | SURVIVAL | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | ADULTS | NATURAL-HISTORY | SOCIETY | END-POINT DEFINITIONS | TRANSCATHETER | IMPLANTATION | PREDICTORS | VALVE-REPLACEMENT | Severity of Illness Index | Echocardiography | Heart Valve Prosthesis Implantation - standards | Follow-Up Studies | Humans | Risk Factors | Male | Treatment Outcome | Aortic Valve Stenosis - diagnosis | Aortic Valve Stenosis - therapy | Propensity Score | Time Factors | Aged, 80 and over | Female | Registries | Aged | Watchful Waiting - standards | Practice Guidelines as Topic | Medical colleges | Care and treatment | Aortic valve stenosis | Cardiovascular agents | College teachers | Cardiology | Epidemiology | Analysis | Hospitalization | Heart attacks | Mortality | Clinical outcomes
Cardiovascular | Internal Medicine | registry | risk | aortic valve replacement | propensity-matched | watchful waiting | SURVIVAL | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | ADULTS | NATURAL-HISTORY | SOCIETY | END-POINT DEFINITIONS | TRANSCATHETER | IMPLANTATION | PREDICTORS | VALVE-REPLACEMENT | Severity of Illness Index | Echocardiography | Heart Valve Prosthesis Implantation - standards | Follow-Up Studies | Humans | Risk Factors | Male | Treatment Outcome | Aortic Valve Stenosis - diagnosis | Aortic Valve Stenosis - therapy | Propensity Score | Time Factors | Aged, 80 and over | Female | Registries | Aged | Watchful Waiting - standards | Practice Guidelines as Topic | Medical colleges | Care and treatment | Aortic valve stenosis | Cardiovascular agents | College teachers | Cardiology | Epidemiology | Analysis | Hospitalization | Heart attacks | Mortality | Clinical outcomes
Journal Article
Optics Express, ISSN 1094-4087, 01/2012, Volume 20, Issue 1, pp. 614 - 620
A 1.3-μm, 4 × 25-Gbit/s, EADFB laser array module with large output power and low driving voltage is developed for 100GbE. A novel rear grating DFB laser is...
Electric Power Supplies | Signal Processing, Computer-Assisted - instrumentation | Lasers | Equipment Design | Telecommunications - instrumentation | Equipment Failure Analysis | Microwaves
Electric Power Supplies | Signal Processing, Computer-Assisted - instrumentation | Lasers | Equipment Design | Telecommunications - instrumentation | Equipment Failure Analysis | Microwaves
Journal Article
Earth, Planets and Space, ISSN 1343-8832, 12/2018, Volume 70, Issue 1, pp. 1 - 19
The status and initial products of the 1-μm camera onboard the Akatsuki mission to Venus are presented. After the successful retrial of Venus’ orbit insertion...
Earth Sciences | Geology | Infrared | Venus | Dayside cloud | Earth Sciences, general | Geophysics/Geodesy | Nightside surface
Earth Sciences | Geology | Infrared | Venus | Dayside cloud | Earth Sciences, general | Geophysics/Geodesy | Nightside surface
Journal Article
INTERNATIONAL JOURNAL OF ONCOLOGY, ISSN 1019-6439, 02/2018, Volume 52, Issue 2, pp. 621 - 629
N-6-methyladenosine (m(6)A) is the most abundant epitranscriptome modification in mammalian mRNA. Recent years have seen substantial progress in m(6)A...
METHYLATION | N6-METHYLADENOSINE | METHYLTRANSFERASE | DNA-DAMAGE RESPONSE | METTL3 | radiosensitivity | HEAT-SHOCK | RNA methylation | MESSENGER-RNA | ONCOLOGY | EMBRYONIC STEM-CELLS | INTERACTION NETWORKS | NUCLEAR-RNA | chemosensitivity | ACTIVATED PROTEIN-KINASES
METHYLATION | N6-METHYLADENOSINE | METHYLTRANSFERASE | DNA-DAMAGE RESPONSE | METTL3 | radiosensitivity | HEAT-SHOCK | RNA methylation | MESSENGER-RNA | ONCOLOGY | EMBRYONIC STEM-CELLS | INTERACTION NETWORKS | NUCLEAR-RNA | chemosensitivity | ACTIVATED PROTEIN-KINASES
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 05/2018, Volume 499, Issue 3, pp. 544 - 550
Oncostatin M (OSM) is involved in pathogenesis of several human inflammatory diseases including lung inflammation and fibrosis. Although accumulating evidence...
VCAM-1 | Lung endothelial cell | Oncostatin M | Traf5 | Lung stromal/fibroblast cells | BIOCHEMISTRY & MOLECULAR BIOLOGY | TISSUE | FIBROBLASTS | CELL-ADHESION MOLECULE-1 | LATE ACTIVATION ANTIGEN-4 | BIOPHYSICS | EOTAXIN EXPRESSION | ENDOTHELIAL-CELLS | DEGRADATION | REQUIRES | EOSINOPHIL ACCUMULATION
VCAM-1 | Lung endothelial cell | Oncostatin M | Traf5 | Lung stromal/fibroblast cells | BIOCHEMISTRY & MOLECULAR BIOLOGY | TISSUE | FIBROBLASTS | CELL-ADHESION MOLECULE-1 | LATE ACTIVATION ANTIGEN-4 | BIOPHYSICS | EOTAXIN EXPRESSION | ENDOTHELIAL-CELLS | DEGRADATION | REQUIRES | EOSINOPHIL ACCUMULATION
Journal Article
OPTICS LETTERS, ISSN 0146-9592, 01/2018, Volume 43, Issue 2, pp. 202 - 205
A 2 mu m Ho-doped ytrrium lithium fluoride (Ho:YLF) laser end-pumped by a 1.94 mu m Tm: fiber laser was developed. A laser system of a ring resonator...
SYSTEM | OPERATION | PERFORMANCE | CO2 | COHERENT | OPTICS | OSCILLATOR | MIXING-RATIO | 2-MU-M DIFFERENTIAL ABSORPTION
SYSTEM | OPERATION | PERFORMANCE | CO2 | COHERENT | OPTICS | OSCILLATOR | MIXING-RATIO | 2-MU-M DIFFERENTIAL ABSORPTION
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
In patients with stable cardiovascular disease, those receiving rivaroxaban plus aspirin had fewer major cardiovascular events but more major bleeding events...
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | ORAL RIVAROXABAN | CLOPIDOGREL | SECONDARY PREVENTION | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Life Sciences | Human health and pathology
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | ORAL RIVAROXABAN | CLOPIDOGREL | SECONDARY PREVENTION | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Life Sciences | Human health and pathology
Journal Article